Atlas Trials

Metastatic Urothelial Cancer

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Urothelial Cancer

RecordFirmDate
Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (NCT05101096)Gilead Sciences2021-10-20
A Study to Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 ( PD 1) / (Programmed Death Ligand-1 (PD-L1) Inhibitor Therapy (NCT04995419)Astellas Pharma China, Inc.2021-07-22
A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) (NCT03679767)Incyte Corporation2019-01-09
Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer (NCT03682068)AstraZeneca2018-09-27
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread (NCT03547973)Gilead Sciences2018-08-13
Avelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma (NCT03390595)Associació per a la Recerca Oncologica, Spain2018-05-17
Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer (NCT03451331)Matthew Galsky2018-05-10
Paclitaxel and TAK-228 in Urothelial Carcinoma (NCT03745911)Associació per a la Recerca Oncologica, Spain2018-05-04
Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations (NCT03448718)Matthew Galsky2018-04-17
A Study of Enfortumab Vedotin in Japanese Subjects With Locally Advanced or Metastatic Urothelial Carcinoma (NCT03070990)Astellas Pharma Inc2017-04-24
Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer (NCT02826564)University Hospital, Ghent2016-11-14
A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function. (NCT02240017)Institut Claudius Regaud2015-01-21
ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer (NCT01963052)Astellas Pharma Global Development, Inc.2013-11-14

Track Metastatic Urothelial Cancer automatically

Every clearance here is in the API, with alerts when new ones post.